Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Pediatr. 2012 Jun 26;161(6):1010–1015.e1. doi: 10.1016/j.jpeds.2012.05.051

Figure.

Figure

Percent of the variation in “final” cardiometabolic outcomes independently accounted for by “final” weight z score and the rate of change in weight z score during risperidone treatment. hsCRP: high-sensitivity C-reactive Protein. MS: Metabolic Syndrome Score.